Home
Pharmathen Pharmaceuticals

Pharmathen Pharmaceuticals Market Share Analysis for June 2026

pharmathen is a research-centered, pharmaceutical company which focuses in developing innovative generic products. pharmathen is providing a complete package of integrated services including finished products, know-how, and technological and regulatory support to its partners worldwide.

Industry: N/A

Domainpharmathen.gr

Year Founded1969

Employees51 - 200

Annual Revenue$2M - $5M

Pharmathen Pharmaceuticals

Pharmathen Pharmaceuticals (including company regionals)

pharmathen.gr

See more website traffic and engagement information

Pharmathen Pharmaceuticals Revenue up to June 2026 is 2M - 5M

revenue generated by Pharmathen Pharmaceuticals top domains

Pharmathen Pharmaceuticals top domains revenue over 3 years

Revenue for Pharmathen Pharmaceuticals top domains

pharmathen.gr2M - 5M

See more with Sales Intelligence

Total visits to Pharmathen Pharmaceuticals's top domains

Understand Pharmathen Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Pharmathen Pharmaceuticals's top domains

Analyze Pharmathen Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Pharmathen Pharmaceuticals's top domains

See how Pharmathen Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Pharmathen Pharmaceuticals top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Pharmathen Pharmaceuticals

These are the website technologies, by industry, used by Pharmathen Pharmaceuticals top domains

Content Management System (2)

Drupal

Mobile (2)

Meta Viewport

Widget (2)

Google Maps

Audio Video Media (1)

YouTube

More Technologies

5

See all

News & Signals from Pharmathen Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPartners Group acquires Pharmathen.Private equity firm Partners Group has agreed to acquire Pharmathen from an international investment firm BC Partners in a deal valued about $1.88bn (€1.6bn).